Metallopharm LLC
- UEI
- JDYPJL3AFLT3
- CAGE
- 416Q8
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Rapid point-of-care diagnosis of wound infection | National Institutes of Health | $224,974 | |
| Definitive Contract HHSN272201400057C | NIAID DEA OA Acquisitions | $224,868 | |
| Sbir phase i: a diagnostic device for bacterial detection | National Science Foundation | $150,000 | |
| Metallodrugs targeting HCV protease | National Institutes of Health | $444,050 | |
| Novel engineered synthetic metallodrugs directed against HCV | National Institutes of Health | $156,722 |
Quick answers
What is Metallopharm LLC's UEI?
Metallopharm LLC's Unique Entity ID (UEI) in SAM.gov is JDYPJL3AFLT3.
What is Metallopharm LLC's CAGE code?
Metallopharm LLC's CAGE code is 416Q8.
What is Metallopharm LLC's primary NAICS code?
Metallopharm LLC's primary NAICS code is 541711 (Research and Development in Biotechnology).
Is Metallopharm LLC registered in SAM.gov?
Metallopharm LLC's SAM.gov registration expired on March 7, 2018.
What is Metallopharm LLC's most recent federal award?
Metallopharm LLC's most recent federal grant award is Rapid point-of-care diagnosis of wound infection (R43NR016164), from National Institutes of Health, on July 6, 2016.
On GovTribe
See Metallopharm LLC's full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors